6G1W
Crystal structure of Torpedo Californica acetylcholinesterase in complex with 2-{1-[2-(6-Chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-1H-1,2,3-triazol-4-yl}-N-[4-(hydroxy)-3-methoxybenzyl]acetamide
Replaces: 6FOVSummary for 6G1W
Entry DOI | 10.2210/pdb6g1w/pdb |
Descriptor | Acetylcholinesterase, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-[1-[2-[(3-chloranylacridin-9-yl)amino]ethyl]-1,2,3-triazol-4-yl]-~{N}-[(3-methoxy-4-oxidanyl-phenyl)methyl]ethanamide, ... (5 entities in total) |
Functional Keywords | torpedo californica acetylcholinesterase, ad, alzheimer disease, hydrolase |
Biological source | Tetronarce californica (Pacific electric ray) |
Total number of polymer chains | 2 |
Total formula weight | 130066.40 |
Authors | Coquelle, N.,Colletier, J.P. (deposition date: 2018-03-22, release date: 2018-04-04, Last modification date: 2024-01-17) |
Primary citation | Galdeano, C.,Coquelle, N.,Cieslikiewicz-Bouet, M.,Bartolini, M.,Perez, B.,Clos, M.V.,Silman, I.,Jean, L.,Colletier, J.P.,Renard, P.Y.,Munoz-Torrero, D. Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis. Molecules, 23:-, 2018 Cited by PubMed: 29534488DOI: 10.3390/molecules23030634 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)